Insider Stock Trading History of Tessmer James F


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Tessmer James F since year 2005. The trader's CIK number is 1434095. At the time of this reporting, Tessmer James F is the VP, Finance & Accounting of Lexicon Pharmaceuticals, Inc. . (stock ticker symbol LXRX). See this page for all insider trading activities at Lexicon Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Tessmer James F since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-06-08 LXRX Lexicon Pharmaceuticals, Inc. Option Ex 10,000 10.15 101,500
2018-06-08 LXRX Lexicon Pharmaceuticals, Inc. Sale 10,000 12.91 129,080
2018-02-28 LXRX Lexicon Pharmaceuticals, Inc. Option Ex 7,353 .00 0
2017-02-28 LXRX Lexicon Pharmaceuticals, Inc. Option Ex 6,939 .00 0
2016-06-06 LXRX Lexicon Pharmaceuticals, Inc. Sale 1,500 15.00 22,500
2016-06-06 LXRX Lexicon Pharmaceuticals, Inc. Option Ex 1,500 6.23 9,345
2016-05-23 LXRX Lexicon Pharmaceuticals, Inc. Option Ex 6,000 6.23 37,380
2016-05-23 LXRX Lexicon Pharmaceuticals, Inc. Sale 6,000 13.00 78,000
2016-02-29 LXRX Lexicon Pharmaceuticals, Inc. Option Ex 5,828 .00 0
2015-03-02 LXRX Lexicon Pharmaceuticals, Inc. Option Ex 29,625 .00 0
2014-02-28 LXRX Lexicon Pharmaceuticals, Inc. Option Ex 20,250 .00 0
2013-02-28 LXRX Lexicon Pharmaceuticals, Inc. Option Ex 14,250 .00 0
2013-01-31 LXRX Lexicon Pharmaceuticals, Inc. Option Ex 13,200 .00 0
2012-02-28 LXRX Lexicon Pharmaceuticals, Inc. Option Ex 7,500 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tessmer James F (VP, Finance & Accounting of Lexicon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.